AIDS Res Hum Retroviruses

1. LIU H, He Y, Yang T, Cai L, et al
   Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.
   AIDS Res Hum Retroviruses. 2026 Aug 10:8892229261394656.
   

   >> Share

   
   

   
   BMJ

2. TU SS, Kesselheim AS
   Pitfalls of announcing regulatory policy in medical journals.
   BMJ. 2026;394:e100438.
   

   >> Share

   
   

   
   Clin Infect Dis

3. 
   Correction to: Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With HIV: Outcomes in Real-world Setting With and Without Tenofovir Resistance.
   Clin Infect Dis. 2026 Aug 13:ciag488. doi: 10.1093.
   

   >> Share

   
   

   
   Drugs

4. BLAIR HA
   Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.
   Drugs. 2026 Aug 13. doi: 10.1007/s40265-026-02368.
   

   >> Share

   
   

   
   HIV Med

5. LAYMOUNA M, Engler K, Lessard D, Belin M, et al
   Material deprivation and its correlates in treatment-naive migrants with HIV with rapid access to B/F/TAF at no cost: A sub-study of the ASAP cohort.
   HIV Med. 2026 Aug 13. doi: 10.1111/hiv.70299.
   

   >> Share

   
   

   
   PLoS One

6. MBONSHI B, Kabemba EM, Bowa C
   Prevalence and determinants of soil transmitted helminth infections among children on Highly Active Antiretroviral Therapy (HAART) in Mulobezi and Sesheke Districts, Zambia: A cross - sectional study.
   PLoS One. 2026;21:e0356060.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share